Gastrointestinal Stromal Tumors

Showing NaN - NaN of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastrointestinal Stromal Tumors Trial in Houston (Regorafenib)

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2023

Gastrointestinal Stromal Tumors Trial in Worldwide (DCC-2618, Placebo Oral Tablet)

Completed
  • Gastrointestinal Stromal Tumors
  • Scottsdale, Arizona
  • +34 more
Nov 17, 2022

Gastrointestinal Stromal Tumors Trial in Japan, United States (DS-6157a)

Completed
  • Gastrointestinal Stromal Tumors
  • Boston, Massachusetts
  • +4 more
Apr 7, 2022

Gastrointestinal Stromal Tumors, Advanced Systemic Mastocytosis, Advanced Cancers Trial in Worldwide (DCC-2618)

Active, not recruiting
  • Gastrointestinal Stromal Tumors
  • +2 more
  • Scottsdale, Arizona
  • +25 more
Apr 16, 2021

Gastrointestinal Stromal Tumors Trial in Worldwide (DCC-2618, Sunitinib)

Unknown status
  • Gastrointestinal Stromal Tumors
  • Scottsdale, Arizona
  • +120 more
Jan 4, 2021

Symptom Inventory for Gastrointestinal Stromal Tumors

Unknown status
  • Gastrointestinal Stromal Tumors
  • Questionnaires
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 9, 2020

Gastrointestinal Stromal Tumors Trial in United States (Imatinib mesylate)

Terminated
  • Gastrointestinal Stromal Tumors
  • Imatinib mesylate
  • Los Angeles, California
  • +12 more
Aug 22, 2013

Gastrointestinal Stromal Tumors (GIST) Registry

Completed
  • Gastrointestinal Stromal Tumors
  • GIST Registry
  • Houston, Texas
    UT MD Anderson Cancer Center
Aug 1, 2012

Gastrointestinal Stromal Tumors Trial in Worldwide (Nilotinib, Best Supportive Care (BSC) +/- imatinib or sunitinib)

Completed
  • Gastrointestinal Stromal Tumors
  • Nilotinib
  • Best Supportive Care (BSC) +/- imatinib or sunitinib
  • Los Angeles, California
  • +34 more
Jun 5, 2012

Gastrointestinal Stromal Tumors Trial in Houston (Imatinib Mesylate (Gleevec))

Completed
  • Gastrointestinal Stromal Tumors
  • Imatinib Mesylate (Gleevec)
  • Houston, Texas
    UT MD Anderson Cancer Center
Aug 4, 2011